74 related articles for article (PubMed ID: 8545121)
1. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.
Lengye E; Singh B; Gum R; Nerlov C; Sabichi A; Birrer M; Boyd D
Oncogene; 1995 Dec; 11(12):2639-48. PubMed ID: 8545121
[TBL] [Abstract][Full Text] [Related]
2. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.
Besser D; Urich M; Sakaue M; Messerschmitt A; Ballmer-Hofer K; Nagamine Y
Oncogene; 1995 Dec; 11(11):2383-91. PubMed ID: 8570190
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the uPA gene in various grades of human glioma cells.
Lakka SS; Bhattacharya A; Mohanam S; Boyd D; Rao JS
Int J Oncol; 2001 Jan; 18(1):71-9. PubMed ID: 11115541
[TBL] [Abstract][Full Text] [Related]
5. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts.
Besser D; Presta M; Nagamine Y
Cell Growth Differ; 1995 Aug; 6(8):1009-17. PubMed ID: 8547215
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
Bhattacharya A; Lakka SS; Mohanam S; Boyd D; Rao JS
Clin Cancer Res; 2001 Feb; 7(2):267-76. PubMed ID: 11234878
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2.
Besser D; Bardelli A; Didichenko S; Thelen M; Comoglio PM; Ponzetto C; Nagamine Y
Oncogene; 1997 Feb; 14(6):705-11. PubMed ID: 9038378
[TBL] [Abstract][Full Text] [Related]
8. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
9. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras.
Lengyel E; Stepp E; Gum R; Boyd D
J Biol Chem; 1995 Sep; 270(39):23007-12. PubMed ID: 7559439
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene.
Gum R; Wang SW; Lengyel E; Yu D; Hung MC; Juarez J; Boyd D
Anticancer Res; 1995; 15(4):1167-72. PubMed ID: 7653995
[TBL] [Abstract][Full Text] [Related]
12. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
[TBL] [Abstract][Full Text] [Related]
13. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product.
Schönthal A; Feramisco JR
New Biol; 1990 Feb; 2(2):143-50. PubMed ID: 2150599
[TBL] [Abstract][Full Text] [Related]
14. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
15. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
16. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
17. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
Ried S; Jäger C; Jeffers M; Vande Woude GF; Graeff H; Schmitt M; Lengyel E
J Biol Chem; 1999 Jun; 274(23):16377-86. PubMed ID: 10347197
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an important role of serine 16 and its phosphorylation in the stabilization of c-Mos.
Pham CD; Vuyyuru VB; Yang Y; Bai W; Singh B
Oncogene; 1999 Jul; 18(30):4287-94. PubMed ID: 10439036
[TBL] [Abstract][Full Text] [Related]
19. Identification of multiple cis-acting elements mediating the induction of prostaglandin G/H synthase-2 by phorbol ester in murine osteoblastic cells.
Okada Y; Voznesensky O; Herschman H; Harrison J; Pilbeam C
J Cell Biochem; 2000 May; 78(2):197-209. PubMed ID: 10842315
[TBL] [Abstract][Full Text] [Related]
20. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
